AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Health Policy
This section explores national and global health policies that need reform or greater visibility. We spotlight policy gaps, highlight areas for change, and share research that can inform and shape future cancer care and delivery systems.
What Does Oncology Have to Do With Advocacy, Anyway?
By Ariana Sutherland
Ask a room full of oncologists who among them is an advocate, and most hands stay down. Now ask whether they educate patients about their care, push back on insurance denials, or speak up when something is wrong.
What Does Oncology Have to Do With Advocacy, Anyway?
By Ariana Sutherland
Ask a room full of oncologists who among them is an advocate, and most hands stay down. Now ask whether they educate patients about their care, push back on insurance denials, or speak up when something is wrong.
What Does Oncology Have to Do With Advocacy, Anyway?
By Ariana Sutherland
Ask a room full of oncologists who among them is an advocate, and most hands stay down. Now ask whether they educate patients about their care, push back on insurance denials, or speak up when something is wrong.
Asking Because We Care: Why SOGI Data Is Essential to Equitable Cancer Care
By Tiffany Go, MPA, CPCHE
LGBTQ+ patients face real cancer care disparities—and without SOGI data, they remain invisible. A health equity leader at Fred Hutch makes the case for standardized, affirming data collection across cancer care settings.
Asking Because We Care: Why SOGI Data Is Essential to Equitable Cancer Care
By Tiffany Go, MPA, CPCHE
LGBTQ+ patients face real cancer care disparities—and without SOGI data, they remain invisible. A health equity leader at Fred Hutch makes the case for standardized, affirming data collection across cancer care settings.
Asking Because We Care: Why SOGI Data Is Essential to Equitable Cancer Care
By Tiffany Go, MPA, CPCHE
LGBTQ+ patients face real cancer care disparities—and without SOGI data, they remain invisible. A health equity leader at Fred Hutch makes the case for standardized, affirming data collection across cancer care settings.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
The Cervical Cancer Paradox: Disparities and Implementing Strategies in South Asia
By Suchit Shashikumar, MBBS; Jin Mou, MD, MSc, MPH, PhD
Cervical cancer remains preventable, yet disparities in South Asia persist. Explore how HPV vaccination, screening gaps, and community-led innovations can transform outcomes in low-resource settings.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
Dr. Barbara Goff on HPV-Related Cancers: How Vaccination and Screening Can Eliminate a Global Health Crisis
By Barbara A. Goff, MD
HPV-related cancers are largely preventable through vaccination and screening. Dr. Barbara Goff explores global disparities, advances in HPV testing, and strategies to eliminate cervical cancer worldwide.
When the Treatment Exists but the Patient Never Gets It: Dispatches from the 2026 Summit on Cancer Health Disparities
By Aayushi Pareek, MD
A powerful dispatch from SCHD26 explores why cancer disparities persist despite scientific advances—and what must change to ensure equitable access to prevention, diagnosis, and treatment.
When the Treatment Exists but the Patient Never Gets It: Dispatches from the 2026 Summit on Cancer Health Disparities
By Aayushi Pareek, MD
A powerful dispatch from SCHD26 explores why cancer disparities persist despite scientific advances—and what must change to ensure equitable access to prevention, diagnosis, and treatment.
When the Treatment Exists but the Patient Never Gets It: Dispatches from the 2026 Summit on Cancer Health Disparities
By Aayushi Pareek, MD
A powerful dispatch from SCHD26 explores why cancer disparities persist despite scientific advances—and what must change to ensure equitable access to prevention, diagnosis, and treatment.
Nepal’s Cancer Burden: A Systematic Review and Meta-Analysis of 15 Years of Evidence
By Dr. Roshan Kumar Mahato; Prof. Sujan Babu Marahatta; Dr. Kyaw Min Htike, DrPH
A comprehensive systematic review reveals Nepal’s rising cancer burden, highlighting late-stage diagnoses, financial toxicity, and the urgent need for national data to guide cancer control strategies.
Nepal’s Cancer Burden: A Systematic Review and Meta-Analysis of 15 Years of Evidence
By Dr. Roshan Kumar Mahato; Prof. Sujan Babu Marahatta; Dr. Kyaw Min Htike, DrPH
A comprehensive systematic review reveals Nepal’s rising cancer burden, highlighting late-stage diagnoses, financial toxicity, and the urgent need for national data to guide cancer control strategies.
Nepal’s Cancer Burden: A Systematic Review and Meta-Analysis of 15 Years of Evidence
By Dr. Roshan Kumar Mahato; Prof. Sujan Babu Marahatta; Dr. Kyaw Min Htike, DrPH
A comprehensive systematic review reveals Nepal’s rising cancer burden, highlighting late-stage diagnoses, financial toxicity, and the urgent need for national data to guide cancer control strategies.
Can a Blood Test Detect Cancer Earlier? What to Know About Liquid Biopsy
By The Cancer News Team
A new study suggests multicancer blood tests could shift cancer diagnoses to earlier stages. Here’s what liquid biopsy is, how MCED tests work, current FDA approvals, benefits, risks, and what patients should know.
Can a Blood Test Detect Cancer Earlier? What to Know About Liquid Biopsy
By The Cancer News Team
A new study suggests multicancer blood tests could shift cancer diagnoses to earlier stages. Here’s what liquid biopsy is, how MCED tests work, current FDA approvals, benefits, risks, and what patients should know.
Can a Blood Test Detect Cancer Earlier? What to Know About Liquid Biopsy
By The Cancer News Team
A new study suggests multicancer blood tests could shift cancer diagnoses to earlier stages. Here’s what liquid biopsy is, how MCED tests work, current FDA approvals, benefits, risks, and what patients should know.
Attorney Henry T. Greely on Navigating Ethical Challenges in Precision Oncology
By The Cancer News Team
A multidisciplinary panel led by Stanford ethicist Henry T. Greely, JD, examines the ethical challenges of precision oncology, including informed consent, access disparities, privacy concerns, and real-world clinical decision-making.
Attorney Henry T. Greely on Navigating Ethical Challenges in Precision Oncology
By The Cancer News Team
A multidisciplinary panel led by Stanford ethicist Henry T. Greely, JD, examines the ethical challenges of precision oncology, including informed consent, access disparities, privacy concerns, and real-world clinical decision-making.
Attorney Henry T. Greely on Navigating Ethical Challenges in Precision Oncology
By The Cancer News Team
A multidisciplinary panel led by Stanford ethicist Henry T. Greely, JD, examines the ethical challenges of precision oncology, including informed consent, access disparities, privacy concerns, and real-world clinical decision-making.
The Effect of Changing Politics on Global Health
By The Cancer News Team
An expert-led discussion from the 2025 Binaytara Global Oncology Summit examines how shifting global politics and funding cuts are reshaping cancer care access worldwide and what it will take to close the global treatment gap.
The Effect of Changing Politics on Global Health
By The Cancer News Team
An expert-led discussion from the 2025 Binaytara Global Oncology Summit examines how shifting global politics and funding cuts are reshaping cancer care access worldwide and what it will take to close the global treatment gap.
The Effect of Changing Politics on Global Health
By The Cancer News Team
An expert-led discussion from the 2025 Binaytara Global Oncology Summit examines how shifting global politics and funding cuts are reshaping cancer care access worldwide and what it will take to close the global treatment gap.